This announcement is a separate document:
海南葫芦娃药业集团股份有限公司2022年第三季度报告
Hainan Huluwa Pharmaceutical Group Co., Ltd. report for the third quarter of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
15:52
Today, the closing price of the national carbon market was 94.22 yuan/ton, down 0.03% from the previous day
15:51
The Ministry of Commerce: The adjustments to the "Directory of Technologies Prohibited from Exporting and Restricted from Exporting in China" are not aimed at specific Industries or specific countries.
15:50
Ministry of Commerce: The European Commission's investigation into China's FSR has many unreasonable practices.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.